Učitavanje...

New Therapies in Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with high rates of mortality and morbidity. Beginning with cetuximab, investigators continue to optimize antibody technology to target cell surface receptors that promote HNSCC growth. Small molecules and oligonucleotides have also...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Trends Cancer
Glavni autori: Santuray, Rodell T., Johnson, Daniel E., Grandis, Jennifer R.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6226306/
https://ncbi.nlm.nih.gov/pubmed/29709262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2018.03.006
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!